nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Methotrexate—breast cancer	0.475	1	CbGbCtD
Trimetrexate—DHFR—nipple—breast cancer	0.00666	0.149	CbGeAlD
Trimetrexate—DHFR—embryo—breast cancer	0.00549	0.123	CbGeAlD
Trimetrexate—DHFR—endometrium—breast cancer	0.00402	0.09	CbGeAlD
Trimetrexate—Trimethoprim—TYMS—breast cancer	0.00385	0.642	CrCbGaD
Trimetrexate—DHFR—uterus—breast cancer	0.0037	0.083	CbGeAlD
Trimetrexate—DHFR—pituitary gland—breast cancer	0.00364	0.0815	CbGeAlD
Trimetrexate—DHFR—adipose tissue—breast cancer	0.00362	0.0811	CbGeAlD
Trimetrexate—DHFR—female reproductive system—breast cancer	0.00333	0.0746	CbGeAlD
Trimetrexate—DHFR—adrenal gland—breast cancer	0.00325	0.0728	CbGeAlD
Trimetrexate—DHFR—bone marrow—breast cancer	0.00314	0.0704	CbGeAlD
Trimetrexate—DHFR—female gonad—breast cancer	0.00303	0.0679	CbGeAlD
Trimetrexate—DHFR—endocrine gland—breast cancer	0.00282	0.0631	CbGeAlD
Trimetrexate—DHFR—lymph node—breast cancer	0.00195	0.0436	CbGeAlD
Trimetrexate—Trimethoprim—CYP3A4—breast cancer	0.00117	0.195	CrCbGaD
Trimetrexate—Trimethoprim—ABCB1—breast cancer	0.000976	0.163	CrCbGaD
Trimetrexate—Body temperature increased—Raloxifene—breast cancer	0.000696	0.00264	CcSEcCtD
Trimetrexate—Body temperature increased—Idarubicin—breast cancer	0.000696	0.00264	CcSEcCtD
Trimetrexate—Convulsion—Vinblastine—breast cancer	0.000694	0.00263	CcSEcCtD
Trimetrexate—Anaemia—Goserelin—breast cancer	0.000687	0.0026	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Paclitaxel—breast cancer	0.000669	0.00254	CcSEcCtD
Trimetrexate—Asthenia—Letrozole—breast cancer	0.000666	0.00252	CcSEcCtD
Trimetrexate—Asthenia—Anastrozole—breast cancer	0.000666	0.00252	CcSEcCtD
Trimetrexate—Vomiting—Exemestane—breast cancer	0.000664	0.00252	CcSEcCtD
Trimetrexate—Convulsion—Melphalan—breast cancer	0.00066	0.0025	CcSEcCtD
Trimetrexate—Rash—Exemestane—breast cancer	0.000659	0.0025	CcSEcCtD
Trimetrexate—Dermatitis—Exemestane—breast cancer	0.000658	0.00249	CcSEcCtD
Trimetrexate—Pruritus—Anastrozole—breast cancer	0.000657	0.00249	CcSEcCtD
Trimetrexate—Pruritus—Letrozole—breast cancer	0.000657	0.00249	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Paclitaxel—breast cancer	0.000656	0.00248	CcSEcCtD
Trimetrexate—Convulsion—Goserelin—breast cancer	0.000644	0.00244	CcSEcCtD
Trimetrexate—Thrombocytopenia—Vinblastine—breast cancer	0.00064	0.00243	CcSEcCtD
Trimetrexate—Hypocalcaemia—Epirubicin—breast cancer	0.00064	0.00242	CcSEcCtD
Trimetrexate—Hyponatraemia—Docetaxel—breast cancer	0.000633	0.0024	CcSEcCtD
Trimetrexate—Vomiting—Ixabepilone—breast cancer	0.000627	0.00237	CcSEcCtD
Trimetrexate—Thrombocytopenia—Tamoxifen—breast cancer	0.000622	0.00236	CcSEcCtD
Trimetrexate—Rash—Ixabepilone—breast cancer	0.000621	0.00235	CcSEcCtD
Trimetrexate—Dermatitis—Ixabepilone—breast cancer	0.000621	0.00235	CcSEcCtD
Trimetrexate—Nausea—Exemestane—breast cancer	0.00062	0.00235	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Epirubicin—breast cancer	0.000619	0.00235	CcSEcCtD
Trimetrexate—Anaemia—Vinorelbine—breast cancer	0.000615	0.00233	CcSEcCtD
Trimetrexate—Fatigue—Chlorambucil—breast cancer	0.000615	0.00233	CcSEcCtD
Trimetrexate—Hyponatraemia—Capecitabine—breast cancer	0.000613	0.00232	CcSEcCtD
Trimetrexate—Confusional state—Goserelin—breast cancer	0.000612	0.00232	CcSEcCtD
Trimetrexate—Thrombocytopenia—Melphalan—breast cancer	0.000609	0.00231	CcSEcCtD
Trimetrexate—Neutropenia—Paclitaxel—breast cancer	0.000601	0.00228	CcSEcCtD
Trimetrexate—Thrombocytopenia—Goserelin—breast cancer	0.000594	0.00225	CcSEcCtD
Trimetrexate—Hypocalcaemia—Doxorubicin—breast cancer	0.000592	0.00224	CcSEcCtD
Trimetrexate—Vomiting—Letrozole—breast cancer	0.00059	0.00224	CcSEcCtD
Trimetrexate—Vomiting—Anastrozole—breast cancer	0.00059	0.00224	CcSEcCtD
Trimetrexate—Feeling abnormal—Chlorambucil—breast cancer	0.000588	0.00223	CcSEcCtD
Trimetrexate—Anaemia—Thiotepa—breast cancer	0.000588	0.00223	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Epirubicin—breast cancer	0.000586	0.00222	CcSEcCtD
Trimetrexate—Nausea—Ixabepilone—breast cancer	0.000585	0.00222	CcSEcCtD
Trimetrexate—Rash—Letrozole—breast cancer	0.000585	0.00222	CcSEcCtD
Trimetrexate—Rash—Anastrozole—breast cancer	0.000585	0.00222	CcSEcCtD
Trimetrexate—Dermatitis—Anastrozole—breast cancer	0.000585	0.00222	CcSEcCtD
Trimetrexate—Dermatitis—Letrozole—breast cancer	0.000585	0.00222	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Doxorubicin—breast cancer	0.000573	0.00217	CcSEcCtD
Trimetrexate—Blood creatinine increased—Capecitabine—breast cancer	0.000572	0.00217	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Docetaxel—breast cancer	0.000567	0.00215	CcSEcCtD
Trimetrexate—Body temperature increased—Chlorambucil—breast cancer	0.000564	0.00214	CcSEcCtD
Trimetrexate—Vomiting—Idarubicin—breast cancer	0.00056	0.00212	CcSEcCtD
Trimetrexate—Vomiting—Raloxifene—breast cancer	0.00056	0.00212	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Docetaxel—breast cancer	0.000556	0.00211	CcSEcCtD
Trimetrexate—Rash—Idarubicin—breast cancer	0.000555	0.0021	CcSEcCtD
Trimetrexate—Rash—Raloxifene—breast cancer	0.000555	0.0021	CcSEcCtD
Trimetrexate—Dermatitis—Raloxifene—breast cancer	0.000555	0.0021	CcSEcCtD
Trimetrexate—Dermatitis—Idarubicin—breast cancer	0.000555	0.0021	CcSEcCtD
Trimetrexate—Nausea—Letrozole—breast cancer	0.000551	0.00209	CcSEcCtD
Trimetrexate—Nausea—Anastrozole—breast cancer	0.000551	0.00209	CcSEcCtD
Trimetrexate—Convulsion—Thiotepa—breast cancer	0.000551	0.00209	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Capecitabine—breast cancer	0.000549	0.00208	CcSEcCtD
Trimetrexate—Fatigue—Tamoxifen—breast cancer	0.000548	0.00207	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Doxorubicin—breast cancer	0.000542	0.00205	CcSEcCtD
Trimetrexate—Feeling abnormal—Vinblastine—breast cancer	0.000539	0.00204	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Capecitabine—breast cancer	0.000538	0.00204	CcSEcCtD
Trimetrexate—Fatigue—Melphalan—breast cancer	0.000536	0.00203	CcSEcCtD
Trimetrexate—Thrombocytopenia—Vinorelbine—breast cancer	0.000532	0.00202	CcSEcCtD
Trimetrexate—Nausea—Raloxifene—breast cancer	0.000523	0.00198	CcSEcCtD
Trimetrexate—Nausea—Idarubicin—breast cancer	0.000523	0.00198	CcSEcCtD
Trimetrexate—Confusional state—Thiotepa—breast cancer	0.000523	0.00198	CcSEcCtD
Trimetrexate—Fatigue—Goserelin—breast cancer	0.000523	0.00198	CcSEcCtD
Trimetrexate—Asthenia—Chlorambucil—breast cancer	0.000512	0.00194	CcSEcCtD
Trimetrexate—Neutropenia—Docetaxel—breast cancer	0.000509	0.00193	CcSEcCtD
Trimetrexate—Thrombocytopenia—Thiotepa—breast cancer	0.000508	0.00192	CcSEcCtD
Trimetrexate—Anaemia—Irinotecan—breast cancer	0.000507	0.00192	CcSEcCtD
Trimetrexate—Anaemia—Mitoxantrone—breast cancer	0.000507	0.00192	CcSEcCtD
Trimetrexate—Pruritus—Chlorambucil—breast cancer	0.000505	0.00191	CcSEcCtD
Trimetrexate—Feeling abnormal—Goserelin—breast cancer	0.0005	0.00189	CcSEcCtD
Trimetrexate—Anaemia—Gemcitabine—breast cancer	0.000494	0.00187	CcSEcCtD
Trimetrexate—Neutropenia—Capecitabine—breast cancer	0.000493	0.00187	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Epirubicin—breast cancer	0.000489	0.00185	CcSEcCtD
Trimetrexate—Anaemia—Fluorouracil—breast cancer	0.000486	0.00184	CcSEcCtD
Trimetrexate—Body temperature increased—Goserelin—breast cancer	0.00048	0.00182	CcSEcCtD
Trimetrexate—Convulsion—Mitoxantrone—breast cancer	0.000476	0.0018	CcSEcCtD
Trimetrexate—Asthenia—Vinblastine—breast cancer	0.000469	0.00178	CcSEcCtD
Trimetrexate—Fatigue—Vinorelbine—breast cancer	0.000468	0.00177	CcSEcCtD
Trimetrexate—Asthenia—Tamoxifen—breast cancer	0.000456	0.00173	CcSEcCtD
Trimetrexate—Convulsion—Fluorouracil—breast cancer	0.000456	0.00173	CcSEcCtD
Trimetrexate—Vomiting—Chlorambucil—breast cancer	0.000454	0.00172	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Doxorubicin—breast cancer	0.000452	0.00171	CcSEcCtD
Trimetrexate—Confusional state—Irinotecan—breast cancer	0.000452	0.00171	CcSEcCtD
Trimetrexate—Confusional state—Mitoxantrone—breast cancer	0.000452	0.00171	CcSEcCtD
Trimetrexate—Pruritus—Tamoxifen—breast cancer	0.000449	0.0017	CcSEcCtD
Trimetrexate—Feeling abnormal—Vinorelbine—breast cancer	0.000448	0.0017	CcSEcCtD
Trimetrexate—Fatigue—Thiotepa—breast cancer	0.000447	0.00169	CcSEcCtD
Trimetrexate—Asthenia—Melphalan—breast cancer	0.000446	0.00169	CcSEcCtD
Trimetrexate—Pruritus—Melphalan—breast cancer	0.00044	0.00167	CcSEcCtD
Trimetrexate—Thrombocytopenia—Mitoxantrone—breast cancer	0.000439	0.00166	CcSEcCtD
Trimetrexate—Thrombocytopenia—Irinotecan—breast cancer	0.000439	0.00166	CcSEcCtD
Trimetrexate—Asthenia—Goserelin—breast cancer	0.000435	0.00165	CcSEcCtD
Trimetrexate—Confusional state—Fluorouracil—breast cancer	0.000433	0.00164	CcSEcCtD
Trimetrexate—Body temperature increased—Vinorelbine—breast cancer	0.000429	0.00163	CcSEcCtD
Trimetrexate—Pruritus—Goserelin—breast cancer	0.000429	0.00163	CcSEcCtD
Trimetrexate—Feeling abnormal—Thiotepa—breast cancer	0.000428	0.00162	CcSEcCtD
Trimetrexate—Thrombocytopenia—Gemcitabine—breast cancer	0.000427	0.00162	CcSEcCtD
Trimetrexate—Hyponatraemia—Epirubicin—breast cancer	0.000427	0.00162	CcSEcCtD
Trimetrexate—Nausea—Chlorambucil—breast cancer	0.000424	0.00161	CcSEcCtD
Trimetrexate—Thrombocytopenia—Fluorouracil—breast cancer	0.00042	0.00159	CcSEcCtD
Trimetrexate—Vomiting—Vinblastine—breast cancer	0.000416	0.00157	CcSEcCtD
Trimetrexate—Anaemia—Paclitaxel—breast cancer	0.000414	0.00157	CcSEcCtD
Trimetrexate—Body temperature increased—Thiotepa—breast cancer	0.00041	0.00155	CcSEcCtD
Trimetrexate—Vomiting—Tamoxifen—breast cancer	0.000404	0.00153	CcSEcCtD
Trimetrexate—Rash—Tamoxifen—breast cancer	0.0004	0.00152	CcSEcCtD
Trimetrexate—Dermatitis—Tamoxifen—breast cancer	0.0004	0.00152	CcSEcCtD
Trimetrexate—Blood creatinine increased—Epirubicin—breast cancer	0.000398	0.00151	CcSEcCtD
Trimetrexate—Vomiting—Melphalan—breast cancer	0.000395	0.0015	CcSEcCtD
Trimetrexate—Hyponatraemia—Doxorubicin—breast cancer	0.000395	0.0015	CcSEcCtD
Trimetrexate—Rash—Melphalan—breast cancer	0.000392	0.00149	CcSEcCtD
Trimetrexate—Dermatitis—Melphalan—breast cancer	0.000392	0.00148	CcSEcCtD
Trimetrexate—Asthenia—Vinorelbine—breast cancer	0.00039	0.00148	CcSEcCtD
Trimetrexate—Nausea—Vinblastine—breast cancer	0.000388	0.00147	CcSEcCtD
Trimetrexate—Convulsion—Paclitaxel—breast cancer	0.000388	0.00147	CcSEcCtD
Trimetrexate—Fatigue—Irinotecan—breast cancer	0.000386	0.00146	CcSEcCtD
Trimetrexate—Fatigue—Mitoxantrone—breast cancer	0.000386	0.00146	CcSEcCtD
Trimetrexate—Vomiting—Goserelin—breast cancer	0.000386	0.00146	CcSEcCtD
Trimetrexate—Pruritus—Vinorelbine—breast cancer	0.000384	0.00146	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Epirubicin—breast cancer	0.000383	0.00145	CcSEcCtD
Trimetrexate—Rash—Goserelin—breast cancer	0.000382	0.00145	CcSEcCtD
Trimetrexate—Dermatitis—Goserelin—breast cancer	0.000382	0.00145	CcSEcCtD
Trimetrexate—Nausea—Tamoxifen—breast cancer	0.000377	0.00143	CcSEcCtD
Trimetrexate—Fatigue—Gemcitabine—breast cancer	0.000376	0.00143	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000375	0.00142	CcSEcCtD
Trimetrexate—Asthenia—Thiotepa—breast cancer	0.000372	0.00141	CcSEcCtD
Trimetrexate—Nausea—Melphalan—breast cancer	0.000369	0.0014	CcSEcCtD
Trimetrexate—Feeling abnormal—Mitoxantrone—breast cancer	0.000369	0.0014	CcSEcCtD
Trimetrexate—Feeling abnormal—Irinotecan—breast cancer	0.000369	0.0014	CcSEcCtD
Trimetrexate—Confusional state—Paclitaxel—breast cancer	0.000368	0.0014	CcSEcCtD
Trimetrexate—Blood creatinine increased—Doxorubicin—breast cancer	0.000368	0.0014	CcSEcCtD
Trimetrexate—Neutropenia—Methotrexate—breast cancer	0.000367	0.00139	CcSEcCtD
Trimetrexate—Pruritus—Thiotepa—breast cancer	0.000367	0.00139	CcSEcCtD
Trimetrexate—Nausea—Goserelin—breast cancer	0.00036	0.00137	CcSEcCtD
Trimetrexate—Feeling abnormal—Gemcitabine—breast cancer	0.00036	0.00136	CcSEcCtD
Trimetrexate—Thrombocytopenia—Paclitaxel—breast cancer	0.000358	0.00136	CcSEcCtD
Trimetrexate—Body temperature increased—Irinotecan—breast cancer	0.000354	0.00134	CcSEcCtD
Trimetrexate—Body temperature increased—Mitoxantrone—breast cancer	0.000354	0.00134	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.000354	0.00134	CcSEcCtD
Trimetrexate—Feeling abnormal—Fluorouracil—breast cancer	0.000354	0.00134	CcSEcCtD
Trimetrexate—Anaemia—Docetaxel—breast cancer	0.000351	0.00133	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000347	0.00131	CcSEcCtD
Trimetrexate—Vomiting—Vinorelbine—breast cancer	0.000345	0.00131	CcSEcCtD
Trimetrexate—Body temperature increased—Gemcitabine—breast cancer	0.000345	0.00131	CcSEcCtD
Trimetrexate—Neutropenia—Epirubicin—breast cancer	0.000344	0.0013	CcSEcCtD
Trimetrexate—Rash—Vinorelbine—breast cancer	0.000343	0.0013	CcSEcCtD
Trimetrexate—Dermatitis—Vinorelbine—breast cancer	0.000342	0.0013	CcSEcCtD
Trimetrexate—Anaemia—Capecitabine—breast cancer	0.00034	0.00129	CcSEcCtD
Trimetrexate—Body temperature increased—Fluorouracil—breast cancer	0.000339	0.00129	CcSEcCtD
Trimetrexate—Vomiting—Thiotepa—breast cancer	0.00033	0.00125	CcSEcCtD
Trimetrexate—Convulsion—Docetaxel—breast cancer	0.000329	0.00125	CcSEcCtD
Trimetrexate—Rash—Thiotepa—breast cancer	0.000327	0.00124	CcSEcCtD
Trimetrexate—Dermatitis—Thiotepa—breast cancer	0.000327	0.00124	CcSEcCtD
Trimetrexate—Nausea—Vinorelbine—breast cancer	0.000323	0.00122	CcSEcCtD
Trimetrexate—Asthenia—Irinotecan—breast cancer	0.000321	0.00122	CcSEcCtD
Trimetrexate—Asthenia—Mitoxantrone—breast cancer	0.000321	0.00122	CcSEcCtD
Trimetrexate—Neutropenia—Doxorubicin—breast cancer	0.000318	0.0012	CcSEcCtD
Trimetrexate—Fatigue—Paclitaxel—breast cancer	0.000315	0.00119	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—MYC—breast cancer	0.000315	0.0015	CbGpPWpGaD
Trimetrexate—Asthenia—Gemcitabine—breast cancer	0.000313	0.00119	CcSEcCtD
Trimetrexate—Confusional state—Docetaxel—breast cancer	0.000312	0.00118	CcSEcCtD
Trimetrexate—Pruritus—Gemcitabine—breast cancer	0.000309	0.00117	CcSEcCtD
Trimetrexate—DHFR—Disease—CHST9—breast cancer	0.000309	0.00147	CbGpPWpGaD
Trimetrexate—Nausea—Thiotepa—breast cancer	0.000308	0.00117	CcSEcCtD
Trimetrexate—Pruritus—Fluorouracil—breast cancer	0.000304	0.00115	CcSEcCtD
Trimetrexate—Thrombocytopenia—Docetaxel—breast cancer	0.000303	0.00115	CcSEcCtD
Trimetrexate—Confusional state—Capecitabine—breast cancer	0.000302	0.00115	CcSEcCtD
Trimetrexate—Feeling abnormal—Paclitaxel—breast cancer	0.000301	0.00114	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—FOXM1—breast cancer	0.0003	0.00143	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—CDKN1B—breast cancer	0.000298	0.00142	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SYNJ2—breast cancer	0.000296	0.00141	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Capecitabine—breast cancer	0.000294	0.00111	CcSEcCtD
Trimetrexate—DHFR—Disease—CCDC88C—breast cancer	0.000293	0.00139	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LGR6—breast cancer	0.000293	0.00139	CbGpPWpGaD
Trimetrexate—Body temperature increased—Paclitaxel—breast cancer	0.000289	0.00109	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—HIST1H2BK—breast cancer	0.000288	0.00137	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—HIST1H2BC—breast cancer	0.000288	0.00137	CbGpPWpGaD
Trimetrexate—Vomiting—Irinotecan—breast cancer	0.000285	0.00108	CcSEcCtD
Trimetrexate—Vomiting—Mitoxantrone—breast cancer	0.000285	0.00108	CcSEcCtD
Trimetrexate—Rash—Mitoxantrone—breast cancer	0.000283	0.00107	CcSEcCtD
Trimetrexate—Rash—Irinotecan—breast cancer	0.000283	0.00107	CcSEcCtD
Trimetrexate—Dermatitis—Irinotecan—breast cancer	0.000282	0.00107	CcSEcCtD
Trimetrexate—Dermatitis—Mitoxantrone—breast cancer	0.000282	0.00107	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—TP53—breast cancer	0.00028	0.00133	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SFRP1—breast cancer	0.000279	0.00133	CbGpPWpGaD
Trimetrexate—Vomiting—Gemcitabine—breast cancer	0.000278	0.00105	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—CDKN1A—breast cancer	0.000275	0.00131	CbGpPWpGaD
Trimetrexate—Rash—Gemcitabine—breast cancer	0.000275	0.00104	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NDUFS3—breast cancer	0.000275	0.00131	CbGpPWpGaD
Trimetrexate—Dermatitis—Gemcitabine—breast cancer	0.000275	0.00104	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—breast cancer	0.000273	0.0013	CbGpPWpGaD
Trimetrexate—Vomiting—Fluorouracil—breast cancer	0.000273	0.00103	CcSEcCtD
Trimetrexate—Rash—Fluorouracil—breast cancer	0.000271	0.00103	CcSEcCtD
Trimetrexate—Dermatitis—Fluorouracil—breast cancer	0.00027	0.00102	CcSEcCtD
Trimetrexate—DHFR—Disease—SHMT1—breast cancer	0.000268	0.00127	CbGpPWpGaD
Trimetrexate—Fatigue—Docetaxel—breast cancer	0.000267	0.00101	CcSEcCtD
Trimetrexate—Nausea—Irinotecan—breast cancer	0.000266	0.00101	CcSEcCtD
Trimetrexate—Nausea—Mitoxantrone—breast cancer	0.000266	0.00101	CcSEcCtD
Trimetrexate—Asthenia—Paclitaxel—breast cancer	0.000262	0.000993	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—RAD51—breast cancer	0.00026	0.00124	CbGpPWpGaD
Trimetrexate—Nausea—Gemcitabine—breast cancer	0.000259	0.000982	CcSEcCtD
Trimetrexate—Fatigue—Capecitabine—breast cancer	0.000259	0.00098	CcSEcCtD
Trimetrexate—Pruritus—Paclitaxel—breast cancer	0.000259	0.00098	CcSEcCtD
Trimetrexate—DHFR—Metabolism—CHST9—breast cancer	0.000259	0.00123	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC2A5—breast cancer	0.000258	0.00123	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL6—breast cancer	0.000256	0.00122	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Docetaxel—breast cancer	0.000255	0.000967	CcSEcCtD
Trimetrexate—Nausea—Fluorouracil—breast cancer	0.000255	0.000966	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TOP2A—breast cancer	0.000254	0.00121	CbGpPWpGaD
Trimetrexate—Anaemia—Methotrexate—breast cancer	0.000253	0.000958	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1B—breast cancer	0.000251	0.0012	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CUL5—breast cancer	0.000249	0.00118	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HEYL—breast cancer	0.000249	0.00118	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Capecitabine—breast cancer	0.000247	0.000936	CcSEcCtD
Trimetrexate—DHFR—Metabolism—COX11—breast cancer	0.000245	0.00117	CbGpPWpGaD
Trimetrexate—Body temperature increased—Docetaxel—breast cancer	0.000245	0.000928	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—AURKA—breast cancer	0.000242	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—NBN—breast cancer	0.000241	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CCND1—breast cancer	0.00024	0.00114	CbGpPWpGaD
Trimetrexate—Body temperature increased—Capecitabine—breast cancer	0.000237	0.000898	CcSEcCtD
Trimetrexate—Convulsion—Methotrexate—breast cancer	0.000237	0.000898	CcSEcCtD
Trimetrexate—Anaemia—Epirubicin—breast cancer	0.000237	0.000896	CcSEcCtD
Trimetrexate—DHFR—Disease—RSPO3—breast cancer	0.000234	0.00111	CbGpPWpGaD
Trimetrexate—Vomiting—Paclitaxel—breast cancer	0.000232	0.00088	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—breast cancer	0.000232	0.0011	CbGpPWpGaD
Trimetrexate—Rash—Paclitaxel—breast cancer	0.00023	0.000873	CcSEcCtD
Trimetrexate—Dermatitis—Paclitaxel—breast cancer	0.00023	0.000872	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—MYC—breast cancer	0.000228	0.00109	CbGpPWpGaD
Trimetrexate—DHFR—Disease—WNT10B—breast cancer	0.000228	0.00108	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TOP2A—breast cancer	0.000227	0.00108	CbGpPWpGaD
Trimetrexate—Confusional state—Methotrexate—breast cancer	0.000225	0.000853	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—breast cancer	0.000224	0.00107	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CDA—breast cancer	0.000224	0.00107	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SHMT1—breast cancer	0.000224	0.00107	CbGpPWpGaD
Trimetrexate—Asthenia—Docetaxel—breast cancer	0.000222	0.000842	CcSEcCtD
Trimetrexate—Convulsion—Epirubicin—breast cancer	0.000222	0.00084	CcSEcCtD
Trimetrexate—DHFR—Disease—GPI—breast cancer	0.000222	0.00106	CbGpPWpGaD
Trimetrexate—Pruritus—Docetaxel—breast cancer	0.000219	0.00083	CcSEcCtD
Trimetrexate—Anaemia—Doxorubicin—breast cancer	0.000219	0.000829	CcSEcCtD
Trimetrexate—Thrombocytopenia—Methotrexate—breast cancer	0.000219	0.000828	CcSEcCtD
Trimetrexate—Nausea—Paclitaxel—breast cancer	0.000217	0.000822	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—AURKA—breast cancer	0.000217	0.00103	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC2A5—breast cancer	0.000216	0.00103	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLCO1B1—breast cancer	0.000216	0.00103	CbGpPWpGaD
Trimetrexate—Asthenia—Capecitabine—breast cancer	0.000215	0.000815	CcSEcCtD
Trimetrexate—Pruritus—Capecitabine—breast cancer	0.000212	0.000804	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—HSP90AA1—breast cancer	0.000212	0.00101	CbGpPWpGaD
Trimetrexate—DHFR—Disease—DLL4—breast cancer	0.000212	0.00101	CbGpPWpGaD
Trimetrexate—Confusional state—Epirubicin—breast cancer	0.000211	0.000798	CcSEcCtD
Trimetrexate—DHFR—Metabolism—APRT—breast cancer	0.000208	0.000992	CbGpPWpGaD
Trimetrexate—Convulsion—Doxorubicin—breast cancer	0.000205	0.000778	CcSEcCtD
Trimetrexate—Thrombocytopenia—Epirubicin—breast cancer	0.000205	0.000775	CcSEcCtD
Trimetrexate—DHFR—Disease—SFRP2—breast cancer	0.000199	0.000947	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HPSE—breast cancer	0.000199	0.000947	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LDHB—breast cancer	0.000199	0.000947	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL31—breast cancer	0.000199	0.000947	CbGpPWpGaD
Trimetrexate—Vomiting—Docetaxel—breast cancer	0.000197	0.000746	CcSEcCtD
Trimetrexate—DHFR—Metabolism—ESRRA—breast cancer	0.000196	0.000932	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ANGPTL4—breast cancer	0.000196	0.000932	CbGpPWpGaD
Trimetrexate—Rash—Docetaxel—breast cancer	0.000195	0.00074	CcSEcCtD
Trimetrexate—Dermatitis—Docetaxel—breast cancer	0.000195	0.000739	CcSEcCtD
Trimetrexate—Confusional state—Doxorubicin—breast cancer	0.000195	0.000739	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CHEK2—breast cancer	0.000194	0.000922	CbGpPWpGaD
Trimetrexate—Fatigue—Methotrexate—breast cancer	0.000192	0.000729	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—MYC—breast cancer	0.000192	0.000915	CbGpPWpGaD
Trimetrexate—Vomiting—Capecitabine—breast cancer	0.000191	0.000722	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—HSP90AA1—breast cancer	0.000189	0.000901	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Doxorubicin—breast cancer	0.000189	0.000717	CcSEcCtD
Trimetrexate—Rash—Capecitabine—breast cancer	0.000189	0.000716	CcSEcCtD
Trimetrexate—Dermatitis—Capecitabine—breast cancer	0.000189	0.000716	CcSEcCtD
Trimetrexate—DHFR—Disease—VCP—breast cancer	0.000189	0.000897	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HMMR—breast cancer	0.000189	0.000897	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ABCC1—breast cancer	0.000189	0.000897	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HADHB—breast cancer	0.000186	0.000884	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPI—breast cancer	0.000186	0.000884	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TGFBI—breast cancer	0.000186	0.000883	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS4X—breast cancer	0.000186	0.000883	CbGpPWpGaD
Trimetrexate—Nausea—Docetaxel—breast cancer	0.000184	0.000697	CcSEcCtD
Trimetrexate—Feeling abnormal—Methotrexate—breast cancer	0.000184	0.000697	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—BRCA1—breast cancer	0.000182	0.000864	CbGpPWpGaD
Trimetrexate—Fatigue—Epirubicin—breast cancer	0.00018	0.000682	CcSEcCtD
Trimetrexate—Nausea—Capecitabine—breast cancer	0.000178	0.000675	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCNE1—breast cancer	0.000178	0.000846	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ELL—breast cancer	0.000177	0.000844	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALDH7A1—breast cancer	0.000177	0.000843	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALDH1A1—breast cancer	0.000177	0.000843	CbGpPWpGaD
Trimetrexate—Body temperature increased—Methotrexate—breast cancer	0.000176	0.000669	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TYMS—breast cancer	0.000175	0.000831	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Epirubicin—breast cancer	0.000172	0.000652	CcSEcCtD
Trimetrexate—DHFR—Metabolism—FHL2—breast cancer	0.00017	0.000808	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PHGDH—breast cancer	0.00017	0.000808	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ADSL—breast cancer	0.00017	0.000808	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NME1—breast cancer	0.00017	0.000808	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—UMPS—breast cancer	0.00017	0.000808	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—H2AFX—breast cancer	0.000168	0.000801	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—E2F1—breast cancer	0.000167	0.000795	CbGpPWpGaD
Trimetrexate—Fatigue—Doxorubicin—breast cancer	0.000167	0.000631	CcSEcCtD
Trimetrexate—DHFR—Metabolism—LDHB—breast cancer	0.000167	0.000793	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—BRIP1—breast cancer	0.000167	0.000793	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HPSE—breast cancer	0.000167	0.000793	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HEY2—breast cancer	0.000166	0.00079	CbGpPWpGaD
Trimetrexate—Body temperature increased—Epirubicin—breast cancer	0.000165	0.000626	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—BRCA2—breast cancer	0.000164	0.000781	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS6KB2—breast cancer	0.000164	0.000781	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IDH1—breast cancer	0.000162	0.000772	CbGpPWpGaD
Trimetrexate—Asthenia—Methotrexate—breast cancer	0.00016	0.000607	CcSEcCtD
Trimetrexate—Feeling abnormal—Doxorubicin—breast cancer	0.000159	0.000604	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CCNE1—breast cancer	0.000159	0.000757	CbGpPWpGaD
Trimetrexate—Pruritus—Methotrexate—breast cancer	0.000158	0.000598	CcSEcCtD
Trimetrexate—DHFR—Metabolism—HMMR—breast cancer	0.000158	0.000752	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCC1—breast cancer	0.000158	0.000752	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA3—breast cancer	0.000158	0.000752	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—BIRC5—breast cancer	0.000157	0.000747	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TYMS—breast cancer	0.000156	0.000743	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TLE3—breast cancer	0.000155	0.000739	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HEY1—breast cancer	0.000154	0.000732	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPARGC1B—breast cancer	0.000153	0.000728	CbGpPWpGaD
Trimetrexate—Body temperature increased—Doxorubicin—breast cancer	0.000153	0.000579	CcSEcCtD
Trimetrexate—DHFR—Disease—RPL23A—breast cancer	0.000151	0.000717	CbGpPWpGaD
Trimetrexate—DHFR—Disease—DLL1—breast cancer	0.000151	0.000717	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—H2AFX—breast cancer	0.00015	0.000716	CbGpPWpGaD
Trimetrexate—Asthenia—Epirubicin—breast cancer	0.00015	0.000568	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—E2F1—breast cancer	0.000149	0.000711	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HIST1H2BK—breast cancer	0.000148	0.000704	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAP2K7—breast cancer	0.000148	0.000704	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HIST1H2BC—breast cancer	0.000148	0.000704	CbGpPWpGaD
Trimetrexate—Pruritus—Epirubicin—breast cancer	0.000148	0.00056	CcSEcCtD
Trimetrexate—DHFR—Metabolism—CA9—breast cancer	0.000144	0.000687	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA4—breast cancer	0.000144	0.000687	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDK2—breast cancer	0.000144	0.000686	CbGpPWpGaD
Trimetrexate—Vomiting—Methotrexate—breast cancer	0.000142	0.000538	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GPX2—breast cancer	0.000141	0.00067	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA2—breast cancer	0.000141	0.00067	CbGpPWpGaD
Trimetrexate—Rash—Methotrexate—breast cancer	0.000141	0.000533	CcSEcCtD
Trimetrexate—Dermatitis—Methotrexate—breast cancer	0.000141	0.000533	CcSEcCtD
Trimetrexate—DHFR—Disease—RPS7—breast cancer	0.000141	0.000669	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS8—breast cancer	0.000141	0.000669	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—BIRC5—breast cancer	0.00014	0.000668	CbGpPWpGaD
Trimetrexate—DHFR—Disease—DKK1—breast cancer	0.000139	0.000664	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPX4—breast cancer	0.000139	0.000662	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SULT1A1—breast cancer	0.000139	0.000662	CbGpPWpGaD
Trimetrexate—Asthenia—Doxorubicin—breast cancer	0.000139	0.000526	CcSEcCtD
Trimetrexate—DHFR—Disease—ALDOA—breast cancer	0.000138	0.000659	CbGpPWpGaD
Trimetrexate—Pruritus—Doxorubicin—breast cancer	0.000137	0.000518	CcSEcCtD
Trimetrexate—DHFR—Disease—JAG2—breast cancer	0.000136	0.000649	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDK4—breast cancer	0.000136	0.000648	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TERT—breast cancer	0.000136	0.000647	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—IDH1—breast cancer	0.000136	0.000646	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTA1—breast cancer	0.000136	0.000646	CbGpPWpGaD
Trimetrexate—DHFR—Disease—WNT1—breast cancer	0.000134	0.000639	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NAT2—breast cancer	0.000134	0.000639	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC2A2—breast cancer	0.000133	0.000635	CbGpPWpGaD
Trimetrexate—Vomiting—Epirubicin—breast cancer	0.000133	0.000503	CcSEcCtD
Trimetrexate—Nausea—Methotrexate—breast cancer	0.000133	0.000502	CcSEcCtD
Trimetrexate—Rash—Epirubicin—breast cancer	0.000132	0.000499	CcSEcCtD
Trimetrexate—Dermatitis—Epirubicin—breast cancer	0.000132	0.000499	CcSEcCtD
Trimetrexate—DHFR—Disease—MTR—breast cancer	0.000131	0.000622	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDK2—breast cancer	0.000129	0.000613	CbGpPWpGaD
Trimetrexate—Nausea—Epirubicin—breast cancer	0.000124	0.00047	CcSEcCtD
Trimetrexate—Vomiting—Doxorubicin—breast cancer	0.000123	0.000466	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—ATM—breast cancer	0.000122	0.000582	CbGpPWpGaD
Trimetrexate—Rash—Doxorubicin—breast cancer	0.000122	0.000462	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—CDK4—breast cancer	0.000122	0.000579	CbGpPWpGaD
Trimetrexate—Dermatitis—Doxorubicin—breast cancer	0.000122	0.000461	CcSEcCtD
Trimetrexate—DHFR—Disease—HSPA1B—breast cancer	0.000122	0.000578	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—RB1—breast cancer	0.000118	0.000563	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MED12—breast cancer	0.000118	0.00056	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—DPYD—breast cancer	0.000118	0.00056	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ENO1—breast cancer	0.000116	0.000554	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALDOA—breast cancer	0.000116	0.000552	CbGpPWpGaD
Trimetrexate—Nausea—Doxorubicin—breast cancer	0.000115	0.000435	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NCOA3—breast cancer	0.000113	0.000535	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC2A2—breast cancer	0.000112	0.000532	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF3—breast cancer	0.00011	0.000524	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTR—breast cancer	0.000109	0.000521	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CPT1A—breast cancer	0.000109	0.000521	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCG2—breast cancer	0.000109	0.000521	CbGpPWpGaD
Trimetrexate—DHFR—Disease—JAG1—breast cancer	0.000109	0.000518	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FASN—breast cancer	0.000109	0.000518	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PARP1—breast cancer	0.000108	0.000515	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HPGDS—breast cancer	0.000107	0.000511	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CALCA—breast cancer	0.000107	0.000509	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HBA1—breast cancer	0.000107	0.000508	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—RB1—breast cancer	0.000106	0.000504	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS6—breast cancer	0.000106	0.000503	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF4—breast cancer	0.000105	0.000499	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CXCR4—breast cancer	0.000104	0.000497	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ACHE—breast cancer	0.000104	0.000495	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTT1—breast cancer	0.000104	0.000495	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC2A1—breast cancer	0.000103	0.000492	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TCF7L2—breast cancer	0.000101	0.000479	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP17A1—breast cancer	9.86e-05	0.000469	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS1—breast cancer	9.76e-05	0.000464	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ENO1—breast cancer	9.76e-05	0.000464	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HSP90AA1—breast cancer	9.71e-05	0.000462	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2D6—breast cancer	9.57e-05	0.000455	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PRL—breast cancer	9.45e-05	0.00045	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NCOA2—breast cancer	9.39e-05	0.000447	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ADAM10—breast cancer	9.31e-05	0.000443	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—breast cancer	9.22e-05	0.000439	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FASN—breast cancer	9.11e-05	0.000433	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—BCHE—breast cancer	9.07e-05	0.000432	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF10—breast cancer	9.06e-05	0.000431	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MDM2—breast cancer	9.03e-05	0.00043	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC5A5—breast cancer	8.96e-05	0.000426	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCND1—breast cancer	8.79e-05	0.000418	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PDGFA—breast cancer	8.74e-05	0.000416	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC2A1—breast cancer	8.65e-05	0.000412	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NQO1—breast cancer	8.65e-05	0.000412	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TGFBR2—breast cancer	8.62e-05	0.00041	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—breast cancer	8.51e-05	0.000405	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ITPR1—breast cancer	8.48e-05	0.000404	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP3A4—breast cancer	8.44e-05	0.000402	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERBB4—breast cancer	8.42e-05	0.000401	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT5A—breast cancer	8.42e-05	0.000401	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP1B1—breast cancer	8.3e-05	0.000395	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN1B—breast cancer	8.24e-05	0.000392	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SMAD4—breast cancer	8.16e-05	0.000388	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HSP90AA1—breast cancer	8.14e-05	0.000387	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HES1—breast cancer	7.96e-05	0.000379	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NCOR1—breast cancer	7.92e-05	0.000377	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NCOA1—breast cancer	7.91e-05	0.000377	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CCND1—breast cancer	7.86e-05	0.000374	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF1—breast cancer	7.83e-05	0.000373	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—STK11—breast cancer	7.8e-05	0.000371	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP19A1—breast cancer	7.8e-05	0.000371	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NRG1—breast cancer	7.77e-05	0.00037	CbGpPWpGaD
Trimetrexate—DHFR—Disease—H2AFX—breast cancer	7.72e-05	0.000367	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN1A—breast cancer	7.61e-05	0.000362	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERCC2—breast cancer	7.45e-05	0.000354	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERBB3—breast cancer	7.28e-05	0.000347	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR2—breast cancer	7.27e-05	0.000346	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK3—breast cancer	7.25e-05	0.000345	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—COMT—breast cancer	7.25e-05	0.000345	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTP1—breast cancer	7.22e-05	0.000343	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMOX1—breast cancer	7.12e-05	0.000339	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ITPR1—breast cancer	7.1e-05	0.000338	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYC—breast cancer	7.05e-05	0.000336	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTHFR—breast cancer	7e-05	0.000333	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TERT—breast cancer	6.98e-05	0.000332	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCB1—breast cancer	6.83e-05	0.000325	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR1—breast cancer	6.78e-05	0.000322	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TYMS—breast cancer	6.71e-05	0.000319	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HIF1A—breast cancer	6.67e-05	0.000318	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLA2G4A—breast cancer	6.63e-05	0.000316	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTM1—breast cancer	6.63e-05	0.000316	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NCOR1—breast cancer	6.63e-05	0.000316	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK3—breast cancer	6.48e-05	0.000309	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CAV1—breast cancer	6.46e-05	0.000307	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPX1—breast cancer	6.35e-05	0.000302	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYC—breast cancer	6.31e-05	0.0003	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP1A1—breast cancer	6.29e-05	0.000299	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ERCC2—breast cancer	6.24e-05	0.000297	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS2—breast cancer	6.07e-05	0.000289	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOTCH1—breast cancer	6.01e-05	0.000286	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APC—breast cancer	5.88e-05	0.00028	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KIT—breast cancer	5.88e-05	0.00028	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTHFR—breast cancer	5.86e-05	0.000279	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EGF—breast cancer	5.81e-05	0.000277	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BRAF—breast cancer	5.53e-05	0.000263	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CAV1—breast cancer	5.41e-05	0.000257	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT2—breast cancer	5.38e-05	0.000256	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TP53—breast cancer	5.18e-05	0.000246	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CD—breast cancer	5.17e-05	0.000246	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SERPINE1—breast cancer	5.11e-05	0.000243	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CG—breast cancer	4.92e-05	0.000234	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS3—breast cancer	4.88e-05	0.000232	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MDM2—breast cancer	4.63e-05	0.00022	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RAF1—breast cancer	4.61e-05	0.00022	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERBB2—breast cancer	4.57e-05	0.000217	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CB—breast cancer	4.51e-05	0.000214	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTOR—breast cancer	4.51e-05	0.000214	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD4—breast cancer	4.5e-05	0.000214	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTGS2—breast cancer	4.46e-05	0.000212	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CD—breast cancer	4.33e-05	0.000206	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—breast cancer	4.27e-05	0.000203	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1B—breast cancer	4.23e-05	0.000201	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NOS3—breast cancer	4.09e-05	0.000195	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CTNNB1—breast cancer	3.99e-05	0.00019	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1A—breast cancer	3.9e-05	0.000186	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTEN—breast cancer	3.89e-05	0.000185	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CB—breast cancer	3.77e-05	0.00018	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS2—breast cancer	3.74e-05	0.000178	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SRC—breast cancer	3.61e-05	0.000172	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT3—breast cancer	3.48e-05	0.000166	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK3—breast cancer	3.33e-05	0.000158	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTEN—breast cancer	3.26e-05	0.000155	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MYC—breast cancer	3.24e-05	0.000154	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TGFB1—breast cancer	3.23e-05	0.000154	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EGFR—breast cancer	3.16e-05	0.000151	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KRAS—breast cancer	2.99e-05	0.000142	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CA—breast cancer	2.75e-05	0.000131	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HRAS—breast cancer	2.54e-05	0.000121	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—breast cancer	2.43e-05	0.000116	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CA—breast cancer	2.3e-05	0.000109	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT1—breast cancer	2.24e-05	0.000107	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AKT1—breast cancer	1.88e-05	8.94e-05	CbGpPWpGaD
